Top

Published in:

01-02-2010

Cheyne-Stokes Respiration in Patients with Heart Failure

Authors: Laila AlDabal, Ahmed S. BaHammam

Published in: Lung | Issue 1/2010

Abstract

Cheyne-Stokes respiration (CSR) is a form of central sleep-disordered breathing (SDB) in which there are cyclical fluctuations in breathing that lead to periods of central apneas/hypopnea, which alternate with periods of hyperpnea. The crescendo–decrescendo pattern of respiration in CSR is a compensation for the changing levels of blood oxygen and carbon dioxide. Severe congestive heart failure seems to be the most important risk factor for the development of CSR. A number of pathophysiologic changes, such as sleep disruption, arousals, hypoxemia-reoxygenation, hypercapnia/hypocapnia, and changes in intrathoracic pressure have harmful effects on the cardiovascular system, and the presence of CSR is associated with increased mortality and morbidity in subjects with variable degrees of heart failure. The management of CSR involves optimal control of underlying heart failure, oxygen therapy, and positive airway pressure support. In this review, we initially define and describe the epidemiology of central sleep apnea (CSA) and CSR, its pathogenesis, clinical presentation, diagnostic methods, and then discuss the recent developments in the management in patients with heart failure.

Cheyne J (1918) A case of apoplexy in which the fleshy part of the heart was converted into fat. Dublin Hospital Reports 2:216–223. Reprinted in Willius FA, Keys TE (1941) Cardiac Classics 317–320

Stokes W (1854) Fatty degeneration of the heart. In: The diseases of the heart and aorta. Dublin, pp 320–327

Tremel F, Pepin JL, Veale D, Wuyam B, Siche JP, Mallion JM et al (1999) High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 20:1201–1209PubMedCrossRef

Hanly P (2004) Sleep apnea and daytime sleepiness in end-stage renal disease. Semin Dial 17:109–114PubMedCrossRef

Siccoli MM, Valko PO, Hermann DM, Bassetti CL (2008) Central periodic breathing during sleep in 74 patients with acute ischemic stroke: neurogenic and cardiogenic factors. J Neurol 255:1687–1692PubMedCrossRef

Khoo MC, Anholm JD, Ko SW, Downey R 3rd, Powles AC, Sutton JR et al (1996) Dynamics of periodic breathing and arousal during sleep at extreme altitude. Respir Physiol 103:33–43PubMedCrossRef

He J, Neal B, Gu D, Suriyawongpaisal P, Xin X, Reynolds R et al (2004) International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. Ethn Dis 14:260–268PubMed

Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9:251–257PubMedCrossRef

McMurray JJV, Stewart S (2002) The burden of heart failure. Eur Heart J Suppl 4:D50–D58CrossRef

10.

Javaheri S, Parker TJ, Wexler L, Michaels SE, Stanberry E, Nishyama H et al (1995) Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 122(7):487–492PubMed

11.

McMurray JJ, Stewart S (2000) Epidemiology, aetiology, and prognosis of heart failure. Heart 83(5):596–602PubMedCrossRef

12.

Javaheri S, Wexler L (2005) Prevalence and treatment of breathing disorders during sleep in patients with heart failure. Curr Treat Options Cardiovasc Med 7(4):295–306PubMedCrossRef

13.

Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F et al (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163(1):19–25PubMed

14.

Lanfranchi PA, Somers VK (2003) Sleep-disordered breathing in heart failure: characteristics and implications. Respir Physiol Neurobiol 136(2–3):153–165PubMedCrossRef

15.

Javaheri S (2006) Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 106(1):21–28PubMedCrossRef

16.

Chan J, Sanderson J, Chan W, Lai C, Choy D, Ho A et al (1997) Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 111(6):1488–1493PubMedCrossRef

17.

Bitter T, Faber L et al (2009) Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail 11(6):602–608PubMedCrossRef

18.

Padeletti M, Green P, Mooney AM, Basner RC, Mancini DM (2009) Sleep disordered breathing in patients with acutely decompensated heart failure. Sleep Med 10(3):353–360PubMedCrossRef

19.

Yoneyama K, Osada N, Shimozato T, Ishibashi Y, Hayashi A, Takahashi E et al (2008) Relationship between sleep-disordered breathing level and acute onset time of congestive heart failure. Int Heart J 49(4):471–480PubMedCrossRef

20.

Naughton MT (2008) Common sleep problems in ICU: heart failure and sleep-disordered breathing syndromes. Crit Care Clin 24(3):565–587, vii–viiiPubMedCrossRef

21.

Skinner MA, Choudhury MS, Homan SD, Cowan JO, Wilkins GT, Taylor DR (2005) Accuracy of monitoring for sleep-related breathing disorders in the coronary care unit. Chest 127(1):66–71PubMedCrossRef

22.

BaHammam A, Al-Mobeireek A, Al-Nozha M, Al-Tahan A, Binsaeed A (2005) Behaviour and time-course of sleep disordered breathing in patients with acute coronary syndromes. Int J Clin Pract 59(8):874–880PubMedCrossRef

23.

Ferrier K, Campbell A, Yee B, Richards M, O’Meeghan T, Weatherall M et al (2005) Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 128(4):2116–2122PubMedCrossRef

24.

Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1101–1106PubMed

25.

Brack T, Thuer I, Clarenbach CF, Senn O, Noll G, Russi EW et al (2007) Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest 132(5):1463–1471PubMedCrossRef

26.

Leung RS, Diep TM, Bowman ME, Lorenzi-Filho G, Bradley TD (2004) Provocation of ventricular ectopy by Cheyne-Stokes respiration in patients with heart failure. Sleep 27(7):1337–1343PubMed

27.

Lanfranchi PA, Somers VK, Braghiroli A, Corra U, Eleuteri E, Giannuzzi P (2003) Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 107(5):727–732PubMedCrossRef

28.

Hanly PJ, Zuberi-Khokhar NS (1996) Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272–276PubMed

29.

Javaheri S (2005) Central sleep apnea in congestive heart failure: prevalence, mechanisms, impact, and therapeutic options. Semin Respir Crit Care Med 26(1):44–55PubMedCrossRef

30.

Brack T (2007) Cheyne-Stokes respiration in patients with heart failure: ominous sign or innocent bystander? Swiss Med Wkly 137(9–10):133–138PubMed

31.

Carmona-Bernal C, Ruiz-Garcia A, Villa-Gil M, Sanchez-Armengol A, Quintana-Gallego E, Ortega-Ruiz F et al (2008) Quality of life in patients with congestive heart failure and central sleep apnea. Sleep Med 9(6):646–651PubMedCrossRef

32.

Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT (1999) Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99(12):1574–1579PubMed

33.

Lorenzi-Filho G, Azevedo ER, Parker JD, Bradley TD (2002) Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure. Eur Respir J 19(1):37–40PubMedCrossRef

34.

Tkacova R, Hall MJ, Liu PP, Fitzgerald FS, Bradley TD (1997) Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am J Respir Crit Care Med 156(5):1549–1555PubMed

35.

Hanly P, Zuberi N, Gray R (1993) Pathogenesis of Cheyne-Stokes respiration in patients with congestive heart failure. Relationship to arterial PCO₂. Chest 104(4):1079-1084

36.

Solin P, Roebuck T, Johns DP, Walters EH, Naughton MT (2000) Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 162(6):2194–2200PubMed

37.

Hall MJ, Xie A, Rutherford R, Ando S, Floras JS, Bradley TD (1996) Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 154(2 Pt 1):376–381PubMed

38.

Cherniack NS, Longobardo G, Evangelista CJ (2005) Causes of Cheyne-Stokes respiration. Neurocrit Care 3(3):271–279PubMedCrossRef

39.

Giannoni A, Emdin M, Poletti R, Bramanti F, Prontera C, Piepoli M et al (2008) Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. Clin Sci (Lond) 114(7):489–497CrossRef

40.

Naughton M, Benard D, Tam A, Rutherford R, Bradley TD (1993) Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 148(2):330–338PubMed

41.

Fanfulla F, Mortara A, Maestri R, Pinna GD, Bruschi C, Cobelli F et al (1998) The development of hyperventilation in patients with chronic heart failure and Cheyne-Strokes respiration: a possible role of chronic hypoxia. Chest 114(4):1083–1090PubMedCrossRef

42.

Hanly PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH (1989) The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 111(10):777–782PubMed

43.

Sahlin C, Svanborg E, Stenlund H, Franklin KA (2005) Cheyne-Stokes respiration and supine dependency. Eur Respir J 25(5):829–833PubMedCrossRef

44.

Lorenzi-Filho G, Genta PR et al (2005) Cheyne-Stokes respiration in patients with congestive heart failure: causes and consequences. Clinics (Sao Paulo) 60(4):333–344

45.

Lorenzi-Filho G, Genta PR (2008) A new straw in the genesis of Cheyne-Stokes respiration. Chest 134(1):7–9PubMedCrossRef

46.

Szollosi I, Krum H, Kaye D, Naughton MT (2007) Sleep apnea in heart failure increases heart rate variability and sympathetic dominance. Sleep 30(11):1509–1514PubMed

47.

Mansfield D, Kaye DM, Brunner La Rocca H, Solin P, Esler MD, Naughton MT (2003) Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 107(10):1396–1400PubMedCrossRef

48.

Hanly P, Zuberi-Khokhar N (1995) Daytime sleepiness in patients with congestive heart failure and Cheyne-Stokes respiration. Chest 107(4):952–958PubMedCrossRef

49.

Yumino D, Bradley TD (2008) Central sleep apnea and Cheyne-Stokes respiration. Proc Am Thorac Soc 5(2):226–236PubMedCrossRef

50.

Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMed

51.

American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689

52.

Xie A, Skatrud JB, Puleo DS, Rahko PS, Dempsey JA (2002) Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med 165(9):1245–1250PubMedCrossRef

53.

Javaheri S (1999) A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341(13):949–954PubMedCrossRef

54.

Series F, Kimoff RJ, Morrison D, Leblanc MH, Smilovitch M, Howlett J et al (2005) Prospective evaluation of nocturnal oximetry for detection of sleep-related breathing disturbances in patients with chronic heart failure. Chest 127(5):1507–1514PubMedCrossRef

55.

Vazir A, Hastings PC, Dayer M, McIntyre HF, Henein MY, Poole-Wilson PA et al (2007) A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 9(3):243–250PubMedCrossRef

56.

Dowdell WT, Javaheri S, McGinnis W (1990) Cheyne-Stokes respiration presenting as sleep apnea syndrome Clinical and polysomnographic features. Am Rev Respir Dis 141(4 Pt 1):871–879PubMed

57.

Szollosi I, Roebuck T, Thompson B, Naughton MT (2006) Lateral sleeping position reduces severity of central sleep apnea/Cheyne-Stokes respiration. Sleep 29(8):1045–1051PubMed

58.

Franklin KA, Sandstrom E, Johansson G, Balfors EM (1997) Hemodynamics, cerebral circulation, and oxygen saturation in Cheyne-Stokes respiration. J Appl Physiol 83(4):1184–1191PubMed

59.

Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73(4):615–621PubMed

60.

Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS et al (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311(13):819–823PubMed

61.

Carmona-Bernal C, Quintana-Gallego E, Villa-Gil M, Sanchez-Armengol A, Martinez-Martinez A, Capote F (2005) Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea. Chest 127(5):1667–1673PubMedCrossRef

62.

Kannel WB (2000) Incidence and epidemiology of heart failure. Heart Fail Rev 5(2):167–173PubMedCrossRef

63.

Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112(12):e154–e235PubMedCrossRef

64.

Stanek EJ, Nara AR, Strohl KP, Nair RN, Decker MJ, Munger MA (1994) Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure. Pharmacotherapy 14(3):321–329PubMed

65.

Javaheri S (2000) Treatment of central sleep apnea in heart failure. Sleep 23(Suppl 4):S224–S227PubMed

66.

Zilberman M, Silverberg DS, Bits I, Steinbruch S, Wexler D, Sheps D et al (2007) Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure. Am Heart J 154(5):870–876PubMedCrossRef

67.

Rigatto H, Brady JP (1972) Periodic breathing and apnea in preterm infants. II. Hypoxia as a primary event. Pediatrics 50(2):219–228PubMed

68.

Lahiri S, Maret K, Sherpa MG (1983) Dependence of high altitude sleep apnea on ventilatory sensitivity to hypoxia. Respir Physiol 52(3):281–301PubMedCrossRef

69.

Dowell AR, Heyman A, Sieker HO, Tripathy K (1965) Effect of aminophylline on respiratory-center sensitivity in Cheyne-Stokes respiration and in pulmonary emphysema. N Engl J Med 273(27):1447–1453PubMedCrossRef

70.

Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M (1997) Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95(6):1363–1365PubMed

71.

Griffiths TL, Christie JM, Parsons ST, Holgate ST (1997) The effect of dipyridamole and theophylline on hypercapnic ventilatory responses: the role of adenosine. Eur Respir J 10(1):156–160PubMedCrossRef

72.

Niemand D, Martinell S, Arvidsson S, Ekstrom-Jodal B, Svedmyr N (1986) Adenosine in the inhibition of diazepam sedation by aminophylline. Acta Anaesthesiol Scand 30(7):493–495PubMedCrossRef

73.

Georgopoulos D, Holtby SG, Berezanski D, Anthonisen NR (1989) Aminophylline effects on ventilatory response to hypoxia and hyperoxia in normal adults. J Appl Physiol 67(3):1150–1156PubMed

74.

Easton PA, Anthonisen NR (1988) Ventilatory response to sustained hypoxia after pretreatment with aminophylline. J Appl Physiol 64(4):1445–1450PubMed

75.

Sanders JS, Berman TM, Bartlett MM, Kronenberg RS (1980) Increased hypoxic ventilatory drive due to administration of aminophylline in normal men. Chest 78(2):279–282PubMedCrossRef

76.

Pesek CA, Cooley R, Narkiewicz K, Dyken M, Weintraub NL, Somers VK (1999) Theophylline therapy for near-fatal Cheyne-Stokes respiration. A case report. Ann Intern Med 130(5):427–430PubMed

77.

Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA (1996) Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 335(8):562–567PubMedCrossRef

78.

Hu K, Li Q, Yang J, Hu S, Chen X (2003) The effect of theophylline on sleep-disordered breathing in patients with stable chronic congestive heart failure. Chin Med J (Engl) 116(11):1711–1716

79.

Huerta C, Lanes SF, Garcia Rodriguez LA (2005) Respiratory medications and the risk of cardiac arrhythmias. Epidemiology 16(3):360–366PubMedCrossRef

80.

Sharp JT, Druz WS, D’Souza V, Diamond E (1985) Effect of metabolic acidosis upon sleep apnea. Chest 87(5):619–624PubMedCrossRef

81.

Swenson ER, Hughes JM (1993) Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol 74(1):230–237PubMed

82.

Teppema LJ, Dahan A (1999) Acetazolamide and breathing Does a clinical dose alter peripheral and central CO(2) sensitivity? Am J Respir Crit Care Med 160(5 Pt 1):1592–1597PubMed

83.

Biberdorf DJ, Steens R, Millar TW, Kryger MH (1993) Benzodiazepines in congestive heart failure: effects of temazepam on arousability and Cheyne-Stokes respiration. Sleep 16(6):529–538PubMed

84.

Munger MA, Stanek EJ, Nara AR, Strohl KP, Decker MJ, Nair RN (1994) Arterial oxygen saturation in chronic congestive heart failure. Am J Cardiol 73(2):180–185PubMedCrossRef

85.

Seino Y, Imai H, Nakamoto T, Araki Y, Sasayama S (2007) Clinical efficacy and cost-benefit analysis of nocturnal home oxygen therapy in patients with central sleep apnea caused by chronic heart failure. Circ J 71(11):1738–1743PubMedCrossRef

86.

Javaheri S, Ahmed M, Parker TJ, Brown CR (1999) Effects of nasal O₂ on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 22(8):1101–1106PubMed

87.

Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H (2006) Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration. Circ J 70(1):1–7PubMedCrossRef

88.

Franklin KA, Eriksson P, Sahlin C, Lundgren R (1997) Reversal of central sleep apnea with oxygen. Chest 111(1):163–169PubMedCrossRef

89.

Staniforth AD, Kinnear WJ, Starling R, Hetmanski DJ, Cowley AJ (1998) Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 19(6):922–928PubMedCrossRef

90.

Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI (1996) Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 27(2):353–357PubMedCrossRef

91.

Andreas S, Clemens C, Sandholzer H, Figulla HR, Kreuzer H (1996) Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 27(6):1486–1490PubMedCrossRef

92.

Brostrom A, Hubbert L, Jakobsson P, Johansson P, Fridlund B, Dahlstrom U (2005) Effects of long-term nocturnal oxygen treatment in patients with severe heart failure. J Cardiovasc Nurs 20(6):385–396PubMed

93.

Steens RD, Millar TW, Su X, Biberdorf D, Buckle P, Ahmed M et al (1994) Effect of inhaled 3% CO2 on Cheyne-Stokes respiration in congestive heart failure. Sleep 17(1):61–68PubMed

94.

Andreas S, Weidel K, Hagenah G, Heindl S (1998) Treatment of Cheyne-Stokes respiration with nasal oxygen and carbon dioxide. Eur Respir J 12(2):414–419PubMedCrossRef

95.

Lorenzi-Filho G, Rankin F, Bies I, Douglas Bradley T (1999) Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159(5 Pt 1):1490–1498PubMed

96.

Garrigue S, Bordier P, Jais P, Shah DC, Hocini M, Raherison C et al (2002) Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 346(6):404–412PubMedCrossRef

97.

Sharafkhaneh A, Sharafkhaneh H, Bredikus A, Guilleminault C, Bozkurt B, Hirshkowitz M (2007) Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med 8(1):31–36PubMedCrossRef

98.

Shalaby AA, Atwood CW, Hansen C, Konermann M, Freedman R, Fowler J et al (2007) Analysis of interaction of acute atrial overdrive pacing with sleep-related breathing disorder. Am J Cardiol 99(4):573–578PubMedCrossRef

99.

Vital FM, Saconato H, Ladeira MT, Sen A, Hawkes CA, Soares B et al. (2008) Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst Rev (3):CD005351

100.

Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT (2004) Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169(3):361–366PubMedCrossRef

101.

Bradley TD (1996) Hemodynamic and sympathoinhibitory effects of nasal CPAP in congestive heart failure. Sleep 19(10 Suppl):S232–S235PubMed

102.

Willson GN, Wilcox I, Piper AJ, Flynn WE, Grunstein RR, Sullivan CE (1998) Treatment of central sleep apnoea in congestive heart failure with nasal ventilation. Thorax 53(Suppl 3):S41–S46PubMedCrossRef

103.

Issa FG, Sullivan CE (1986) Reversal of central sleep apnea using nasal CPAP. Chest 90(2):165–171PubMedCrossRef

104.

Willson GN, Wilcox I, Piper AJ, Flynn WE, Norman M, Grunstein RR et al (2001) Noninvasive pressure preset ventilation for the treatment of Cheyne-Stokes respiration during sleep. Eur Respir J 17(6):1250–1257PubMedCrossRef

105.

Krachman SL, Crocetti J, Berger TJ, Chatila W, Eisen HJ, D’Alonzo GE (2003) Effects of nasal continuous positive airway pressure on oxygen body stores in patients with Cheyne-Stokes respiration and congestive heart failure. Chest 123(1):59–66PubMedCrossRef

106.

Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD (1995) Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152(2):473–479PubMed

107.

Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD (2000) Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 102(1):61–66PubMed

108.

Liston R, Deegan PC, McCreery C, Costello R, Maurer B, McNicholas WT (1995) Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J 8(3):430–435PubMedCrossRef

109.

Buckle P, Millar T, Kryger M (1992) The effect of short-term nasal CPAP on Cheyne-Stokes respiration in congestive heart failure. Chest 102(1):31–35PubMedCrossRef

110.

Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D et al (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115(25):3173–3180PubMedCrossRef

111.

Ruttanaumpawan P, Logan AG, Floras JS, Bradley TD (2009) Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep 32(1):91–98PubMed

112.

Kasai T, Narui K, Dohi T, Ishiwata S, Yoshimura K, Nishiyama S et al (2005) Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with cheyne-stokes respiration and central sleep apnea. Circ J 69(8):913–921PubMedCrossRef

113.

Dohi T, Kasai T, Narui K, Ishiwata S, Ohno M, Yamaguchi T et al (2008) Bi-level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ J 72(7):1100–1105PubMedCrossRef

114.

Teschler H, Dohring J, Wang YM, Berthon-Jones M (2001) Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164(4):614–619PubMed

115.

Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR et al (2003) A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168(9):1109–1114PubMedCrossRef

116.

Philippe C, Stoica-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L et al (2006) Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six-month period. Heart 92(3):337–342PubMedCrossRef

117.

Randerath WJ, Galetke W, Stieglitz S, Laumanns C, Schafer T (2008) Adaptive servo-ventilation in patients with coexisting obstructive sleep apnoea/hypopnoea and Cheyne-Stokes respiration. Sleep Med 9(8):823–830PubMedCrossRef

118.

Fietze I, Blau A, Glos M, Theres H, Baumann G, Penzel T (2008) Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Med 9(6):652–659PubMedCrossRef

119.

Hu K, Li QQ, Yang J, Chen XQ, Hu SP, Wu XJ (2006) The role of high-frequency jet ventilation in the treatment of Cheyne-Stokes respiration in patients with chronic heart failure. Int J Cardiol 106(2):224–231PubMedCrossRef

120.

Sinha AM, Skobel EC, Breithardt OA, Norra C, Markus KU, Breuer C et al (2004) Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 44(1):68–71PubMedCrossRef

121.

Skobel EC, Sinha AM, Norra C, Randerath W, Breithardt OA, Breuer C et al (2005) Effect of cardiac resynchronization therapy on sleep quality, quality of life, and symptomatic depression in patients with chronic heart failure and Cheyne-Stokes respiration. Sleep Breath 9(4):159–166PubMedCrossRef

122.

Murdock DK, Lawless CE, Loeb HS, Scanlon PJ, Pifarre R (1986) The effect of heart transplantation on Cheyne-Stokes respiration associated with congestive heart failure. J Heart Transplant 5(4):336–337PubMed

123.

Gabor JY, Newman DA, Barnard-Roberts V, Korley V, Mangat I, Dorian P et al (2005) Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy. Eur Respir J 26(1):95–100PubMedCrossRef

124.

Tomcsanyi J, Karlocai K, Papp L (1994) Disappearance of periodic breathing after heart operations. J Thorac Cardiovasc Surg 107(1):317–318PubMed

125.

Thalhofer S, Kiwus U, Dorow P (2000) Influence of orthotopic heart transplantation on breathing pattern disorders in patients with dilated cardiomyopathy. Sleep Breath 4(3):121–126PubMedCrossRef

126.

Mansfield DR, Solin P, Roebuck T, Bergin P, Kaye DM, Naughton MT (2003) The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest 124(5):1675–1681PubMedCrossRef

127.

Collop NA (1993) Cheyne-Stokes ventilation converting to obstructive sleep apnea following heart transplantation. Chest 104(4):1288–1289PubMedCrossRef

Title: Cheyne-Stokes Respiration in Patients with Heart Failure
Authors: Laila AlDabal
Ahmed S. BaHammam
Publication date: 01-02-2010
Publisher: Springer-Verlag
Published in: Lung / Issue 1/2010
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-009-9200-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Dexamethasone and Cyclic AMP Regulate Sodium Phosphate Cotransporter (NaPi-IIb and Pit-1) mRNA and Phosphate Uptake in Rat Alveolar Type II Epithelial Cells

Biopsy-Proven Pulmonary Determinants of Heart Disease

Can We Improve Sleep Quality by Changing the Way We Ventilate Patients?

Serum Protein Profiling of Smear-Positive and Smear-Negative Pulmonary Tuberculosis Using SELDI-TOF Mass Spectrometry

Erratum to: Glutathione and Malondialdehyde Levels in Late Pulmonary Complications of Sulfur Mustard Intoxication

Glutathione and Malondialdehyde Levels in Late Pulmonary Complications of Sulfur Mustard Intoxication

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials